Polycystic ovary syndrome - modern concepts

Cover Page

Cite item


The article reviews current concepts of etiology and pathogenesis of polycystic ovary syndrome. Currently, numerous forms of the syndrome, manifesting by a variety of clinical, morphologic signs and features of endocrine profile, exist. It was revealed that polycystic ovary syndrome is a multifactorial, genetically determined disease. Laboratory diagnosis in females with polycystic ovary syndrome is based on measuring concentrations of hormones. Results of ovarian sonography are of a great importance, allowing to diagnose polycystic ovary syndrome. Another method of instrumental diagnosis is laparoscopy, revealing two-sided growth ovarian hypertrophy and multiple subcapsular cysts. Ovarian capsule looks thickened, smooth, with a marked vascular pattern. Treatment depends on the clinical features and intensity of symptoms, as well as on patient’s interest in pregnancy. The choice of treatment options should be supported by clinical and laboratory data, considering pathogenetic type of the disease. The treatment of polycystic ovary syndrome includes conservative and surgical approaches. The main targets of drug treatment is the cessation of clinical and metabolic symptoms of the disease, decreasing the symptoms of virilescence, restoring the menstrual cycle and ovulation induction. Indication for surgical treatment is non-efficiency of drug treatment in restoring fertility. Thereby, multiple factors determining clinical symptoms and morphologic changes in ovaries, including central mechanisms of pituitary gland gonadotropic function, local ovarian factors, extraovarial endocrine and metabolic disorders, participate in pathogenesis of polycystic ovary syndrome. The early initiation of treatment in patients with polycystic ovary syndrome may preserve the fertility, as well as prevent hyper- and neoplastic diseases of endothelium, and the syndrome’s late complications.

About the authors

M E Azizova

Azerbaijan Medical University, Baku, Azerbaijan

Author for correspondence.
Email: rjafarova@bk.ru


  1. Богатырёва Е.М. Современные представления о синдроме поликистозных яичников // Педиатр. - 2010. - Т. 1, №1. - С. 36-42.
  2. Захарова Н.Н., Дворянский С.А. Синдром поликистозных яичников // Вятский мед. вестн. - 2010. - №2. - С. 3-8.
  3. Зеленина Н.В., Молчанов О.Л., Бескровный С.В. Терапия бесплодия при синдроме поликистозных яичников // Педиатр. - 2011. - Т. 2, №4. - С. 76-81.
  4. Зеленина Н.В., Бескровный С.В., Молчанов О.Л. Синдром поликистозных яичников - проявление социально-адаптационного напряжения // Рос. вестн. акуш.-гинекол. - 2012. - Т. 12, №3. - С. 67-74.
  5. Кулиева Н.А., Багирова X.Ф. Результаты оперативного лечения женского бесплодия при синдроме поликистозных яичников в разных возрастных группах // Врач-аспирант. - 2010. - Т. 40, №3, прил. 1. - С. 111-115.
  6. Парамонова О.В., Коренская Е.Г., Трофименко А.С., Зборовская И.А. Синдром поликистозных яичников в репродуктивном возрасте: современные воззрения на патогенез и клинические проявления // Пробл. жен. здоровья. - 2013. - Т. 8, №2. - С. 74-80.
  7. Симонова О.С., Сандакова Е.А., Терещенко И.В. Спорные вопросы патогенеза синдрома поликистозных яичников // Пермский мед. ж. - 2006. - Т. 23, №1. - С. 125-132.
  8. Соболева Е.Л. Состояние углеводного обмена при синдроме поликистозных яичников // Пробл. эндокринол. - 2012. - Т. 58, №5. - С. 41-45.
  9. Соболева Е.Л. Диагностика и патогенетическая терапия синдрома поликистозных яичников // Доктор.Ру. - 2007. - №6. - С. 25-27.
  10. Татарчук Т.Ф., Педаченко Н.Ю., Капшук И.М. Состояние жировой ткани при синдроме поликистозных яичников // Здоровье женщины. - 2013. - №10. - С. 35-38.
  11. Терешин А.Т., Ахкубекова Н.К., Ермолаев О.Ю. и др. Диагностическая и оперативная лапароскопия при синдроме поликистозных яичников // Паллиатив. мед. и реабилит. - 2010. - №2. - С. 38-45.
  12. Ehrmann D.A. Polycystic ovary syndrome // New Engl. J. Med. - 2005. - Vol. 352, N 12. - P. 1223-1236.
  13. Katsiki N., Georgiadou E., Hatzitolios A.I. The role of insulin-sensitizing agents in the treatment of polycystic ovary syndrome // Drugs. - 2009. - Vol. 69, N 11. - P. 1417-1431.
  14. Rotterdam ESHRE /ASRM-Sponsored Consensus Workshop Group 2004. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome // Hum. Reprod. - 2004. - Vol. 19, N 1. - P. 41-47.

© 2015 Azizova M.E.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies